Mark Jeng

机构：Memorial Sloan Kettering Cancer Center

发表论文 1 篇

代表论文

• PP01.20: Integrating Clinicopathologic and Genomic Features to Identify Patients at Risk of Earlier Progression to First-Line Osimertinib in EGFR-Mutant NSCLC (2026 · Journal of Thoracic Oncology)